このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Wearable Sensors and Video-Based Testing to Track Arm Function After Treatment for Neurogenic Thoracic Outlet Syndrome

2026年11月13日 更新者:Bryan M. Burt, MD, FACS、University of California, Los Angeles

Remote Assessment and Digital Biomarker-Based Testing for Neurogenic Thoracic Outlet Syndrome: Longitudinal Follow-up After Physical Therapy or Surgery (Study 2)

The goal of this study is to learn whether wearable motion sensors and video-based movement analysis can track changes in arm function over time in adults with neurogenic thoracic outlet syndrome (NTOS) who are receiving standard treatment (physical therapy or surgery).

NTOS happens when nerves between the neck and shoulder are squeezed, causing pain, numbness, weakness, and trouble using the arm. There is currently no objective test to measure how severe NTOS is or how well treatment is working.

The main questions this study aims to answer are:

  • Can digital measurements of arm movement, collected with wearable sensors and with standard webcam video, detect changes in arm function after NTOS treatment?
  • Are these digital measurements more sensitive to change than standard questionnaires?
  • Do video-based measurements agree with sensor-based measurements?
  • Can measurements taken before treatment help predict who will improve with physical therapy?

This study does not assign or change treatment. Physical therapy or surgery is chosen by each participant's doctors as part of usual care.

Participants will:

  • Complete 5 study visits over about 12 months: before treatment and 1 and 2 months after treatment (in clinic), and 6 and 12 months after treatment (remote telemedicine visits)
  • At each visit, perform a short arm movement task (the "Press Test," a 20-second hand-over-head exercise) while wearing motion sensors and/or being recorded on video
  • Complete questionnaires about arm function, pain, mood, and overall health

調査の概要

状態

まだ募集していません

条件

詳細な説明

Neurogenic thoracic outlet syndrome (NTOS) is a disorder of dynamic compression of the brachial plexus between the first rib and the scalene muscles. Diagnosis currently relies on subjective clinical assessment, and there are no objective measures to monitor response to treatment. This study evaluates a remote patient monitoring platform that extracts digital biomarkers of upper extremity motor function from the Press Test, a 20-second repetitive hand-over-head task designed to provoke NTOS symptoms.

This is a single-site, prospective longitudinal study at the UCLA Thoracic Outlet Syndrome Center. Adults with a treating-physician diagnosis of NTOS who are proceeding with standard-of-care treatment (physical therapy and/or surgery) are followed for 12 months. Treatment selection is made by the treating clinicians and is not assigned by the study. Approximately 50 participants undergoing physical therapy and 50 undergoing surgery will be enrolled.

At each of five time points (baseline 0-1 month before treatment; 1, 2, 6, and 12 months after treatment), participants perform the Press Test while digital biomarkers are captured with wearable inertial sensors and with AI-based analysis of standard webcam video. The baseline, 1-month, and 2-month assessments are performed in person; the 6- and 12-month assessments are performed remotely via secure telehealth, with sensors provided in clinic or mailed to the participant with written instructions and staff support. Patient-reported outcomes (DASH, VAS pain, Zung Self-Rating Depression Scale, and PROMIS Global Health) are collected at each time point. Feasibility and acceptability of remote assessment are evaluated through visit completion rates, time burden, technical issues, and a technology acceptance questionnaire.

Analyses will use linear and generalized linear mixed models to assess change over time, intraclass correlation coefficients and Bland-Altman analyses to compare sensor- and video-derived measures, and exploratory models to identify baseline predictors of response to physical therapy.

This study is funded by the National Institutes of Health (R01HD121303).

研究の種類

観察的

入学 (推定)

100

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

18年~60年 (大人)

健康ボランティアの受け入れ

なし

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

Adults aged 18 to 60 years with a treating-physician diagnosis of neurogenic thoracic outlet syndrome who are evaluated at the UCLA Thoracic Outlet Syndrome Center and are proceeding with standard-of-care physical therapy or surgery.

説明

Inclusion Criteria:

  • Men or women aged 18 to 60 years
  • Treating-physician diagnosis of neurogenic thoracic outlet syndrome (NTOS)
  • Plan for standard-of-care treatment (physical therapy and/or surgery) at UCLA
  • Right-handed, left-handed, or ambidextrous
  • Able to provide informed consent and complete study activities

Exclusion Criteria:

  • Bilateral NTOS
  • Previous surgery for NTOS at any time, or NTOS-directed physical therapy within the past 2 months
  • Venous thoracic outlet syndrome
  • Arterial thoracic outlet syndrome
  • NTOS together with another condition affecting the upper extremity
  • Cognitive impairment
  • Acute or chronic conditions unrelated to NTOS that may affect upper extremity function (e.g., stroke, Parkinson's disease, arthritis, cancer)
  • History of drug or alcohol abuse within the past 6 months
  • Inability to participate in follow-up assessments (e.g., plans to move out of state within 12 months, or inability to complete remote follow-up visits)

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:COHORT
  • 時間の展望:PROSPECTIVE

コホートと介入

グループ/コホート
Physical Therapy

Adults with neurogenic thoracic outlet syndrome whose treating physician has recommended standard-of-care physical therapy. Participants complete digital biomarker assessments (Press Test with wearable sensors and webcam video) and patient-reported outcome questionnaires before treatment and at 1, 2, 6, and 12 months after treatment. Treatment is not assigned by the study.

Surgery

Adults with neurogenic thoracic outlet syndrome whose treating physician has recommended standard-of-care surgical decompression (e.g., first rib resection, scalenectomy, and brachial plexus neurolysis). Participants complete digital biomarker assessments (Press Test with wearable sensors and webcam video) and patient-reported outcome questionnaires before treatment and at 1, 2, 6, and 12 months after treatment. Treatment is not assigned by the study.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Change in Press Test Digital Biomarkers of Upper Extremity Function
時間枠:Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

Digital biomarkers of upper extremity motor function (representing slowness, weakness, rigidity, exhaustion, and unsteadiness, e.g., speed, power, rise time, and range of motion) extracted from a 20-second repetitive hand-over-head Press Test using wearable inertial sensors and AI-based webcam video analysis. Change from baseline will be assessed at each follow-up time point.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
Change in Disabilities of the Arm, Shoulder and Hand (DASH) Score
時間枠:Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

The DASH is a 30-item self-reported questionnaire of upper extremity disability and symptoms. Scores range from 0 to 100; higher scores indicate greater disability.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

二次結果の測定

結果測定
メジャーの説明
時間枠
Change in Pain Intensity (Visual Analog Scale)
時間枠:Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

Self-reported pain intensity on a 0 to 10 visual analog scale; higher scores indicate worse pain.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
Change in Zung Self-Rating Depression Scale (SDS) Score
時間枠:Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

20-item self-reported depression scale. Raw scores range from 20 to 80; higher scores indicate more severe depressive symptoms.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
Change in PROMIS Global Health Physical and Mental Health T-Scores
時間枠:Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

PROMIS Global Health v1.2 (10 items) yields Global Physical Health and Global Mental Health T-scores (population mean 50, SD 10); higher scores indicate better health.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
Agreement Between Sensor-Based and Video-Based Digital Biomarkers
時間枠:Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

Agreement between digital biomarkers derived from wearable sensors and from AI-based webcam video analysis during the Press Test, assessed by intraclass correlation coefficient (ICC) at each time point.

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment
Baseline Digital Biomarkers as Predictors of Response to Physical Therapy
時間枠:Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

Performance of machine learning models using pre-treatment digital biomarkers, demographics, and clinical factors to predict non-response to physical therapy (no meaningful symptom improvement), reported as area under the ROC curve (AUC).

Baseline (0-1 month before treatment) and 1, 2, 6, and 12 months after treatment

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年11月20日

一次修了 (推定)

2030年11月1日

研究の完了 (推定)

2031年11月1日

試験登録日

最初に提出

2026年11月13日

QC基準を満たした最初の提出物

2026年11月13日

最初の投稿 (実際)

2026年11月19日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月19日

QC基準を満たした最後の更新が送信されました

2026年11月13日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

その他の研究ID番号

  • IRB-26-0380-Study2
  • R01HD121303 (米国 NIH グラント/契約)

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。